company

FARMATJENESTER AS

2090 HURDAL

Return on Equity
29,74 %
Current Ratio
3,78
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue678 000
Net Income372 000
Total Assets1 629 000
Total Equity1 251 000
Income (NOK)2022
Revenue678 000
Expenditure212 000
Operating Profit466 000
Financial Income12 000
Financial Costs0
Financial Balance12 000
Earnings Before Tax477 000
Tax105 000
Net Income372 000
Balance (NOK)2022
Total Fixed Assets200 000
Total Current Assets1 429 000
Total Assets1 629 000
Total Retained Equity1 221 000
Total Equity1 251 000
Total Long-Term Debt0
Total Current Debt378 000
Total Equity and Debt1 629 000
Cash flow (NOK)2022
Sales Income678 000
Other Income0
Revenue678 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure212 000
Operating Profit466 000
Financial Income12 000
Financial Costs0
Financial Balance12 000
Dividends200 000
Net Income372 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets200 000
Total Fixed Assets200 000
Stock0
Total Investments0
Cash, Bank1 202 000
Total Current Assets1 429 000
Total Assets1 629 000
Total Equity1 251 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors4 000
Unpaid Taxes42 000
Dividends200 000
Other Current Debt27 000
Total Current Debt378 000
Total Equity and Debt1 629 000
Financial indicators2022
Return on Equity29,74 %
Debt-to-Equity Ratio0
Operating Profit Margin68,73 %
Current Ratio3,78
Quick Ratio3,78
Equity Ratio0,77
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English